Maat Pharma SacaMATPF
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$7.96avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Maat Pharma Saca (MATPF) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Propel Bio Management, LLC ($25K).
- Company
- Maat Pharma Saca
- CUSIP
- F5888J116
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 754 shares bought, net +754 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Propel Bio Management, LLC | 0.02% | Add +31.5% | 3,151 | $25K |
"% of holder's portfolio" is MATPF's weight in each manager's 13F, not the share of Maat Pharma Saca the manager owns.